Showing results (251-260 of 3,995) with videos related to
Sort By:
Pageof 400
Journal of Molecular Graphics & Modelling|February 27, 2009
Comprehensive structural characterization of the cyclic disulphide-bridged nonapeptides, Arg- and Lys-conopressinsGábor Janzsó, Gábor Rákhely, Balázs LeitgebJournal of Molecular Graphics & Modelling|January 27, 2009
Coulomb energies of protein-protein complexes with monopole-free charge distributionsMadhurima Das, Gautam BasuJournal of Molecular Graphics & Modelling|August 7, 2009
Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1Yan Li, Bingcheng Zhou, Renxiao WangJournal of Molecular Graphics & Modelling|September 15, 2009
Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5Calvin Yu-Chian ChenJournal of Molecular Graphics & Modelling|September 22, 2009
Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi trypanothione reductaseSamuel Silva da Rocha Pita, José Jair Vianna Cirino, Ricardo Bicca de Alencastro, et al.Journal of Molecular Graphics & Modelling|October 6, 2009
Assaying phenothiazine derivatives as trypanothione reductase and glutathione reductase inhibitors by theoretical docking and molecular dynamics studiesF Iribarne, M Paulino, S Aguilera, et al.Journal of Molecular Graphics & Modelling|April 2, 2010
2D binary QSAR modeling of LPA3 receptor antagonismJames I Fells, Ryoko Tsukahara, Jianxiong Liu, et al.Journal of Molecular Graphics & Modelling|February 7, 2009
Bridging the gap between molecular descriptors and mechanism: cases studies by molecular dynamics simulationsLiang Xu, Xicheng Wang, Weijie ZhaoJournal of Molecular Graphics & Modelling|February 16, 2010
Why pyridine containing pyrido[2,3-d]pyrimidin-7-ones selectively inhibit CDK4 than CDK2: insights from molecular dynamics simulationNahren Manuel Mascarenhas, Dhananjay Bhattacharyya, Nanda GhoshalJournal of Molecular Graphics & Modelling|February 16, 2010
A comprehensive structure-activity analysis of protein kinase B-alpha (Akt1) inhibitorsSubhash Ajmani, Avantika Agrawal, Sudhir A KulkarniPageof 400